Clinical Trials

NCT04044859 | ACTIVE_NOT_RECRUITING | PHASE1
120 participants

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2019-08-20
Completion:
2026-12-23
Conditions
  • Endometrial Cancer
  • Esophageal Cancer
  • Esophagogastric Junction (EGJ)
  • Gastric (Stomach) Cancer
  • Head and Neck Cancer
  • Melanoma
  • Ovarian Cancer
  • Non-small Cell Lung (NSCLC)
  • Urothelial Cancer
Interventions
  • GENETIC
No Results Yet
NCT04007770 | ACTIVE_NOT_RECRUITING | PHASE2
48 participants

Acupuncture Pilot Study for Cancer-related Cognitive Function

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2019-07-01
Completion:
2027-07-31
Conditions
  • Stage I Breast Cancer
  • Stage II Breast Cancer
  • Stage III Breast Cancer
  • Stage I Colorectal Cancer
  • Stage II Colorectal Cancer
  • Stage III Colorectal Cancer
  • Gynecologic Cancer
  • Stage I Gynecologic Cancer
  • Stage II Gynecologic Cancer
  • Stage III Gynecologic Cancer
  • Stage I Prostate Cancer
  • Stage II Prostate Cancer
  • Stage III Prostate Cancer
Interventions
  • OTHER
No Results Yet
NCT03943173 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
15 participants

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2019-06-07
Completion:
2027-06-27
Conditions
  • BRCA-Mutated Ovarian Carcinoma
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • High Grade Fallopian Tube Serous Adenocarcinoma
  • High Grade Ovarian Serous Adenocarcinoma
  • Primary Peritoneal High Grade Serous Adenocarcinoma
  • Stage III Fallopian Tube Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Primary Peritoneal Cancer AJCC v8
  • Stage IIIA Fallopian Tube Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA Primary Peritoneal Cancer AJCC v8
  • Stage IIIA1 Fallopian Tube Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Fallopian Tube Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Fallopian Tube Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIB Primary Peritoneal Cancer AJCC v8
  • Stage IIIC Fallopian Tube Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
  • Stage IVA Fallopian Tube Cancer AJCC v8
  • Stage IVA Ovarian Cancer AJCC v8
  • Stage IVA Primary Peritoneal Cancer AJCC v8
  • Stage IVB Fallopian Tube Cancer AJCC v8
  • Stage IVB Ovarian Cancer AJCC v8
  • Stage IVB Primary Peritoneal Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT03440567 | COMPLETED | PHASE1
16 participants

Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2018-04-02
Completion:
2024-06-24
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT03244995 | ACTIVE_NOT_RECRUITING | NA
74 participants

Mind-Body Intervention in Glioma Couples

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2017-08-06
Completion:
2028-12-31
Conditions
  • Glioblastoma
  • Low Grade Glioma
  • Malignant Glioma
  • Metastatic Malignant Neoplasm in the Brain
  • Partner
  • WHO Grade III Glioma
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT03206099 | RECRUITING
20000 participants

NIAID Centralized Sequencing Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-12
Start Date:
2017-07-31
Completion:
2029-12-31
Conditions
  • Atopy
  • Primary Immunodeficiency
  • Autoimmunity
  • Autoinflammation
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page